Internal Medicine, Hematology & Oncology · Oklahoma City, OK
NPI
1265813513
Since 2015
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
920 Stanton L Young Blvd, Wp 1130
Oklahoma City, OK, 73104
Phone (405) 271-5963
Groups this clinician bills Medicare through
Medicare paid, 2024
$92K
966 services
Medicare patients, 2024
355
Average age 73
Drug cost, 2024
$10.1M
2,040 prescriptions
Company payments, 2025
$8,095
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adanma Anji Ayanambakkam Attanathi was code 99215 (office e&m - established), 614 times for 235 patients. In total Adanma Anji Ayanambakkam Attanathi billed 966 services in 9 codes, and Medicare paid $92K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-28.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 614 | 235 | $99.35 | $61K |
| 99214 Office E&M - Established | Office | 107 | 78 | $70.72 | $7,567 |
| 99205 Office E&M - New | Office | 84 | 84 | $126.70 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 63 | 37 | $58.77 | $3,703 |
| 99222 Hospital E&M - Initial | Facility | 38 | 37 | $96.73 | $3,676 |
| 99233 Hospital E&M - Subsequent | Facility | 37 | 20 | $88.43 | $3,272 |
| 99223 Hospital E&M - Initial | Facility | 13 | 13 | $129.11 | $1,678 |
By year: 2022 $66K for 707 services; 2023 $99K for 1,008 services; 2024 $92K for 966 services.
Medicare prescription drug claims, 2024
In 2024, the drug Adanma Anji Ayanambakkam Attanathi prescribed most often to Medicare patients was Prednisone, with 301 prescriptions and refills. In total Adanma Anji Ayanambakkam Attanathi wrote 2,040 Medicare prescriptions that cost $10.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 301 | 320 | 77 | $1,556 |
| Abiraterone Acetate Generic | 239 | 239 | 32 | $192K |
| Xtandi Enzalutamide | 146 | 146 | 19 | $1.9M |
| Nubeqa Darolutamide | 123 | 123 | 22 | $1.5M |
| Inlyta Axitinib | 105 | 105 | 18 | $1.9M |
| Cabometyx Cabozantinib S-Malate | 100 | 100 | 22 | $2.5M |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 87 | 87 | 30 | $1,650 |
| Oxycodone Hcl Generic | 81 | 81 | 21 | $1,329 |
| Ondansetron Hcl Generic | 70 | 70 | 52 | $584 |
| Morphine Sulfate Er Morphine Sulfate | 69 | 69 | 20 | $1,411 |
| Ondansetron Odt Ondansetron | 51 | 51 | 30 | $1,377 |
| Prochlorperazine Maleate Generic | 50 | 50 | 36 | $1,191 |
| Levothyroxine Sodium Generic | 46 | 62 | 13 | $137 |
| Eliquis Apixaban | 44 | 52 | 11 | $32K |
| Gabapentin Generic | 36 | 39 | 20 | $575 |
Brand drugs: 681 claims; generic drugs: 1,359 claims; opioid claims: 271.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adanma Anji Ayanambakkam Attanathi $8,095 ($6,495 in general payments such as food, travel and fees and $1,600 for research) from 8 companies. The largest payer was Janssen Biotech, Inc. with $6,049.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.